Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK840 (GSK'840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds the RIP3 kinase domain (IC50: 0.9 nM), and inhibits kinase activity (IC50: 0.3 nM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 11,500 | |||
5 mg | 在庫あり | ¥ 20,500 | |||
10 mg | 在庫あり | ¥ 29,000 | |||
25 mg | 在庫あり | ¥ 45,500 | |||
50 mg | 在庫あり | ¥ 68,500 | |||
100 mg | 在庫あり | ¥ 102,500 |
ターゲット&IC50 | RIP3:0.3 nM , RIP3 kinase domain:0.9 nM |
別名 | GSK'840 |
分子量 | 365.43 |
分子式 | C21H23N3O3 |
CAS No. | 2361146-30-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 110 mg/mL (301.02 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK840 2361146-30-5 Apoptosis NF-Κb RIP kinase GSK 840 Inhibitor GSK-840 GSK'840 Receptor-interacting protein kinases inhibit RIPK inhibitor